Coagulation Test Changes Associated with Acute Normovolemic Hemodilution in Cardiac Surgery
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-003298
NCT ID: NCT03647644
Sponsor Protocol Number: 16-003298
About this study
The specific aim of this study is to determine best practice in management of cardiac surgical patients with post- cardiopulmonary bypass (CBP)coagulopathy and bleeding. The aim is to compare outcomes in patients who receive acute normovolemic hemodilution (ANH) blood to control patients with post-CPB factor mediated coagulopathy and clinically significant microvascular bleeding who have did not receive ANH.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- 18 years of age or older
- Undergoing a cardiac surgical procedure utilizing cardiopulmonary bypass
- Permission to use medical records in research
Exclusion Criteria:
- Unable to grant informed consent or comply with study procedure
- Patient refusal of FWB withdrawal.
- Undergoing emergency open heart-surgery
- Less than 18 years of age
- Pregnant
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Mark Smith, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available